相关实验视频
Updated: Jan 14, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
通过激活STAT3/BCAT1通路,PTGFRN促进非小细胞肺癌恶性进展,并通过激活STAT3/BCAT1通路重新编程BCAA代谢
Feiye Liu1, Mengjie Li2, Peng Yu3
1Respiratory Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Fuoshan, Guangdong 528042, China; Oncology Center of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Fuoshan, Guangdong 528042, China.
前列腺素F2受体负调节器 (PTGFRN) 通过增强STAT3/BCAT1信号传递和分支链氨基酸代谢来促进非小细胞肺癌. 沉默PTGFRN可以抑制瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 前列腺素F2受体负调节剂 (PTGFRN) 涉及癌症转移,但其在肺癌中的作用尚不清楚.
- 了解PTGFRN的功能和调节对于开发向肺癌疗法至关重要.
研究的目的:
- 研究PTGFRN在非小细胞肺癌 (NSCLC) 中的作用和机制.
- 在肺癌进展中阐明PTGFRN调节的信号通路.
主要方法:
- 在肺癌组织和正常组织中对PTGFRN表达的定量分析.
- 在体外和体内实验涉及PTGFRN沉默NSCLC细胞的实验.
- 同免疫沉测试以确定蛋白质相互作用.
- 分析STAT3和BCAT1表达及其对BCAA代谢的下游影响.
主要成果:
- 在NSCLC组织中,PTGFRN表达显著上调,与患者生存率差相关.
- 抑制PTGFRN抑制NSCLC细胞增殖,瘤形成和转移.
- PTGFRN与STAT3相互作用,抑制其降解并导致STAT3积累.
- 累积的STAT3通过与其促进体结合来增强BCAT1的表达,从而促进BCAA代谢.
结论:
- 通过增强STAT3/BCAT1信号轴,PTGFRN在NSCLC中起到瘤促进作用.
- 通过重编程分支链氨基酸代谢,PTGFRN促进癌症的进展.
- 向PTGFRN可能代表NSCLC的新疗法策略.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle